This inventor holds 1 USPTO granted patent. Top assignees: Asahi Kasei Pharma Corporation, National University Corporation Asahikawa Medical University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 84 
1 out of 17 Years Active: 2020
Title: Hiroshi Ito: Innovator in Osteonecrosis Treatment
Introduction
Hiroshi Ito is a notable inventor based in Asahikawa, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of idiopathic osteonecrosis of the femoral head. His innovative approach has the potential to improve patient outcomes and advance medical science.
Latest Patents
Hiroshi Ito holds 1 patent for an agent designed to prevent the onset of idiopathic osteonecrosis of the femoral head and to suppress its progression. The patent addresses a critical problem in the medical field by providing a solution that includes parathyroid hormone or a derivative as an active ingredient, characterized by intermittent administration.
Career Highlights
Throughout his career, Hiroshi Ito has worked with prominent organizations, including Asahi Kasei Pharma Corporation and National University Corporation Asahikawa Medical University. His experience in these institutions has allowed him to collaborate with other experts and contribute to groundbreaking research.
Collaborations
Hiroshi Ito has collaborated with Hiromasa Tanino, further enhancing his research and development efforts in the medical field.
Conclusion
Hiroshi Ito's work in developing treatments for osteonecrosis showcases his dedication to innovation in medicine. His contributions are vital for advancing healthcare solutions and improving the quality of life for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile